Join our
Investor Newsletter

To receive Investor News as it is released please sign up

News Releases

Appointment of Nomad and Joint Broker

February 14, 2019
Download  full announcement   Further to the announcement on 20 December 2018, Renalytix AI plc (AIM: RENX), a developer of artificial intelligence-enabled diagnostics for kidney disease, announces the appointment of Stifel as the Company’s nominated adviser and joint broker with immediate effect.

Clarification re. lock-up restrictions for Distribution Shares

January 21, 2019
Download  full announcement   This announcement relates solely to ordinary shares in the Company which were distributed to certain qualifying shareholders owning EKF Diagnostic Holdings plc shares prior to admission (the “Distribution Shares”). Holders of Distribution Shares are reminded that these

Planned appointment of joint broker and change of nominated adviser

December 20, 2018
Download  full announcement   Renalytix AI plc (AIM: RENX), a developer of artificial intelligence (“AI”) enabled clinical diagnostics solutions for kidney disease, notes the announcement today by EKF Diagnostics Holdings plc (AIM: EKF) and confirms that it has agreed a different resolution to the

Director / PDMR Shareholding

December 20, 2018
Download  full announcement   The Company was informed that today, Christopher Mills, a non-executive director, completed the purchase of 3,168 ordinary shares of 0.25 pence each (“Ordinary Shares”) in the Company at a price of 112 pence per share. Following this purchase, Mr Mills is interested in

Director Dealing

December 19, 2018
Download  full announcement   The Company was informed that today, Christopher Mills, a non-executive director, completed the purchase of 5,970 ordinary shares of 0.25 pence each (“Ordinary Shares”) in the Company at a price of 103 pence per share. Following this purchase, Mr Mills is interested in

TR-1: Standard form for notification of major holdings

December 14, 2018
Download  full announcement   NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer  and  to the FCA in Microsoft Word format if possible) i   1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii : Renalytix AI Plc 1b.
Displaying 211 - 220 of 230